Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1981American Journal of Hematology

Epinephrine potentiation of arachidonate‐induced aggregation of cyclooxygenase‐deficient platelets

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does epinephrine pretreatment normalize arachidonate-induced aggregation in cyclooxygenase-deficient platelets?

Population

A young woman without history of hemorrhagic problems with platelet cyclooxygenase deficiency (n=1)

Comparison

In vitro epinephrine pretreatment (5 micro M) vs No epinephrine pretreatment / normal platelets /…

Design

Case_report

Authors

GRG. H. RaoMinneapolis Heart Institute FoundationJWJames G. WhiteUniversity of Hawaiʻi at Mānoa

Discussion

Loading...

Member takes

Overview

Epinephrine may restore aggregation in COX-deficient platelets without thromboxane; hypothesis-generating for mechanisms of mild bleeding phenotypes.

Key Points

  • The research aims to assess how epinephrine affects platelet aggregation in cyclooxygenase-deficient platelets.
  • Evaluated platelet function and characteristics in a young woman with cyclooxygenase deficiency.
  • Tested platelet aggregation response to various agents including arachidonate and epinephrine.
  • Utilized normal and aspirin-treated platelet-rich plasma for comparison.
  • Epinephrine preexposure normalized platelet response to arachidonate, indicated by primary waves of aggregation.
  • No endoperoxides or thromboxanes were produced, yet aggregation response improved.
  • Cyclooxygenase deficiency did not lead to significant bleeding symptoms despite aggregation challenges.

Structured PICO

Does epinephrine pretreatment normalize arachidonate-induced aggregation in cyclooxygenase-deficient platelets?

P
Population
A young woman without history of hemorrhagic problems with platelet cyclooxygenase deficiency (n=1)
I
Intervention
In vitro epinephrine pretreatment (5 micro M)
C
Comparator
No epinephrine pretreatment / normal platelets / aspirin-treated normal platelets
O
Outcome
Platelet aggregation in response to arachidonic acid (AA)surrogate

Epinephrine can potentiate arachidonate-induced aggregation in cyclooxygenase-deficient platelets without thromboxane generation, potentially explaining the mild bleeding phenotype in these patients.

Cite This Study

Rao et al. (1981) studied this question.

synapsesocial.com/papers/6a70d7d9f44fa9f079de90d8https://doi.org/10.1002/ajh.2830110404
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impairment of Platelet Thromboxane A<sub>2</sub> Generation and of the Platelet Release Reaction in Two Patients with Congenital Deficiency of Platelet Cyclo‐oxygenase1978 · 76 citations
  2. 2Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency.1975 · 307 citations
  3. 3Some Effects of Fibrinogen Degradation Products (FDP) on Blood Platelets1966 · 156 citations
  4. 4Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.1977 · 409 citations
  5. 5Labile Aggregation Stimulating Substance (LASS): the Factor from Storage Pool Deficient Platelets Correcting Defective Aggregation and Release of Aspirin Treated Normal Platelets1975 · 41 citations